Professional Marketing briefs

Janssen is reassuming ex-US marketing rights for its Caeylx/Doxil cancer treatment. Merck has marketed the drug abroad since 1996. That deal expires at the end of the year, and marketing rights for the drug will revert to Janssen subsidiary Alza Corp. Janssen currently markets the product in the US, Japan and Israel under the Doxil brand. announced a partnership with Veeva Systems to bring Veeva's CRM applications to the pharma industry via the cloud computing firm's site. “Veeva is now's premier independent software vendor for sales force automation in the pharmaceutical and biotechnology segment,” said Veeva CEO Peter Gassner.

Physicians Interactive and OptimizerRx launched SampleMD, a virtual sampling program that allows docs to download sample vouchers, prescription co-pay coupons and other support information to their computers. A partnership allows each company to distribute the other's digital products and to develop a joint program that they hope will establish a “one stop shop” for vouchers, samples, co-pay programs and other patient support.

Next Article in Features

The most recent MM&M Skill Sets Live event, "Personalizing the Healthcare Experience," surveyed a range of issues relating to some of the industry's hottest topics. This e-book conveys a wealth of information and opinion designed to help marketers demystify the challenges associated with the personalization of healthcare messaging. Click here to access.